Thanks to improved therapies, more than 80 percent of U.S. children with cancer now become long-term survivors. An estimated 420,000 childhood cancer survivors live in the U.S. alone, with many more around the world.
St. Jude leads some of the world’s most ambitious research programs in childhood cancer survivorship. With unique data gathered from tens of thousands of cancer survivors, we are identifying the long-term effects of cancer therapy; finding better ways to predict health risks; and working to help survivors everywhere live longer, healthier lives.
St. Jude LIFE Study
St. Jude LIFE is an unprecedented study in which thousands of former St. Jude cancer patients periodically return to our campus for comprehensive clinical evaluations throughout their adult lives.
Findings from this unique cohort have yielded novel insights into the long-term effects of pediatric cancers and their treatments, and are informing new approaches to improve long-term survivor health.
Childhood Cancer Survivor Study
St. Jude is the coordinating center for the Childhood Cancer Survivor Study (CCSS). This multi-institutional collaboration is the world’s single largest resource for survivorship research.
Through this initiative, we are analyzing comprehensive treatment exposure and self-reported outcomes data for more than 35,000 survivors, including thousands who were treated at St. Jude.